Balyasny Asset Management
DPLO

Balyasny Asset Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Balyasny Asset Management’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-500,000
Closed -$2.45M – 1619
2019
Q3 		$2.45M Buy
+500,000
New +$2.8M 0.02% 686

Other funds holding DPLO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Balyasny Asset Management's DPLO Position: Q1 2020 in Review

Balyasny Asset Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 367,121 shares — an estimated $1.47M sold.

Balyasny Asset Management first reported a position in DPLO in Q4 2016 and held it in 11 quarters. The position peaked at $31.1M in Q1 2017. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

  • Balyasny Asset Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
  • Balyasny Asset Management sold 367,121 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $1.47M.
  • Balyasny Asset Management first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2016 and held it in 11 quarters.
  • Balyasny Asset Management's DIPLOMAT PHARMACY, INC. position peaked at $31.1M in Q1 2017.
  • 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on Balyasny Asset Management's 13F filing for Q1 2020, filed 15 May 2020.